Both in Biotechnology
BioCardia vs Jasper Therapeutics
Over the past year BCDA returned −35.1% and JSPR returned −75.8%; their daily moves had a correlation of -0.03.
BCDA −35.1% JSPR −75.8%Growth of $1, one year, split-adjusted
| Metric | BCDA | JSPR |
|---|---|---|
| Price | $0.9019 | $0.5080 |
| Market cap | $13.7M | $16.9M |
| Today | +4.75% | −2.35% |
| 1 month | −13.3% | −10.1% |
| 6 months | −20.2% | −48.5% |
| Year to date | −27.8% | −72.2% |
| 1 year | −28.4% | −76.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.1M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 69.2% | 81.7% |
| Short % of float | 6.2% | 22.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).